Skip to main content

Table 6 Comparison of the Oxford classification according to the location of immunofluorescence deposits at diagnosis

From: Immunofluorescence deposits in the mesangial area and glomerular capillary loops did not affect the prognosis of immunoglobulin a nephropathy except C1q:a single-center retrospective study

Parameters

N

M1 (%)

E1 (%)

S1 (%)

T (1 + 2) (%)

C (1 + 2) (%)

IgA

Mesangial-only

251

4.8

7.6

69.7

73.3

35.9

 

Mesangial +GCLs

86

5.6

7.0

77.9

73.9

43.0

 

P

 

0.244

0.856

0.145

0.679

0.237

IgG

(−)

258

4.7

7.8

71.7

76.4

36.0

 

Mesangial-only

32

6.3

9.4

68.8

56.3 a

43.8

 

Mesangial +GCLs

33

15.2 a

6.1

78.8

69.7

42.4

 

P

 

0.037

0.882

0.627

0.044

0.575

IgM

(−)

199

6.0

9.5

69.8

77.9

42.2

 

Mesangial-only

102

3.9

5.9

70.6

66.7

28.4

 

Mesangial +GCLs

35

8.6

0.0

85.7

71.4

37.1

 

P

 

0.553

0.108

0.150

0.105

0.065

C3

(−)

162

4.9

8.6

69.8

74.7

34.6

 

Mesangial-only

127

4.7

6.3

70.9

74.8

40.2

 

Mesangial +GCLs

46

10.9

6.5

80.4

69.6

41.3

 

P

 

0.259

0.728

0.355

0.758

0.533

Fib

(−)

299

6.4

8.0

70.9

75.3

36.8

 

Mesangial-only

17

0.0

0.0

82.4

64.7

47.1

 

Mesangial +GCLs

19

0.0

5.3

73.7

57.9

36.8

 

P

 

0.297

0.440

0.583

0.171

0.695

C1q

(−)

303

5.3

7.6

71.0

74.3

38.3

 

Mesangial-only

19

5.3

10.5

84.2

68.4

36.8

 

Mesangial +GCLs

14

7.1

0.0

71.4

71.4

21.4

 

P

 

0.955

0.497

0.461

0.836

0.444

  1. Abbreviations: Fib Fibrinogen, IgG (−) without IgG deposits, IgM (−) without IgM deposits, C3(−) without C3 deposits, Fib (−) without Fib deposits, C1q (−) without C1q deposits, GCLs glomerular capillary loops, M mesangial hypercellularity, E endocapillary hypercellularity, S segmental glomerulosclerosis, T tubular atrophy/interstitial fibrosis, C Cellular or fibrocellular crescents
  2. * P compare between the IgA groups
  3. a P compare with (−) group
  4. b P compare with the Mesangial-only group
  5. Statistically significant at P < 0.05
  6. The patients with immune deposits in the GCLs group were excluded due to the small sample size